Home › Funds › Occam Crest Management LP › IMRX
Occam Crest Management LP position in IMRX
IMMUNEERING CORP · Health Care
Occam Crest Management LP reported holding 324,698 shares of IMRX (IMMUNEERING CORP) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.75% of its reported portfolio and ranking #22 among its reported holdings. Occam Crest Management LP has disclosed IMRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Occam Crest Management LP's IMRX position evolved
Occam Crest Management LP first disclosed a stake in IMRX in Q3 2025 at 498,498 shares (US$3.5M). Across 5 filings, Occam Crest Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 324,698 shares valued at US$1.3M — an increase of 46,200 shares quarter over quarter.. Notable position changes include a 49% trim in Q2 2026 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 498.50K | $3.49M | New |
| Q4 2025 | 498.50K | $3.28M | Hold |
| Q1 2026 | 545.10K | $2.87M | Add |
| Q2 2026 | 278.50K | $1.13M | Reduce |
| Q3 2026 | 324.70K | $1.33M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMRX and 13F data
IMRX (IMMUNEERING CORP) is a Health Care company. 50 other funds we track also report a position in IMRX — the largest reported positions include Sanofi (US$11.1M), DCF Advisers, LLC (US$3.5M), ALETHEA CAPITAL MANAGEMENT, LLC (US$1.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMRX
- Sanofi 2.71M sh · $11.09M · Q3 2026
- DCF Advisers, LLC 862.50K sh · $3.53M · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 472.94K sh · $1.94M · Q3 2026
- Prosight Management, LP 150.00K sh · $614.25K · Q3 2026
More on Occam Crest Management LP
FAQ
How long has Occam Crest Management LP held IMRX?
Occam Crest Management LP has disclosed IMRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Occam Crest Management LP's current position in IMRX?
As of Q3 2026, Occam Crest Management LP holds 324.70K shares of IMRX (IMMUNEERING CORP), valued at $1.33M, representing 0.75% of its reported portfolio and ranking #22.
Has Occam Crest Management LP been buying or selling IMRX?
In the latest 13F filing (Q3 2026), Occam Crest Management LP increased its position in IMRX.
Which other funds hold IMRX?
Other major institutional holders of IMRX include Sanofi, DCF Advisers, LLC, ALETHEA CAPITAL MANAGEMENT, LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.